Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pheochromocytoma × Melphalan × Clear all

Sponsor

Conditions

Multiple Myeloma 97 Lymphoma 44 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 39 Myelodysplastic Syndromes 36 Leukemia, Myeloid, Acute 36 Leukemia 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Leukemia, Lymphocytic, Chronic, B-Cell 24 Neoplasms, Plasma Cell 21 Lymphoma, Mantle-Cell 20 Lymphoma, Follicular 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, B-Cell, Marginal Zone 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Burkitt Lymphoma 14 Myeloproliferative Disorders 13 Immunoglobulin Light-chain Amyloidosis 13 Recurrence 12 Primary Myelofibrosis 12 Leukemia, Myeloid, Accelerated Phase 12 Hematologic Neoplasms 11 Congenital Abnormalities 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myelomonocytic, Juvenile 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Chronic-Phase 10 Lymphoma, T-Cell, Cutaneous 9 Blast Crisis 9 Anemia, Aplastic 9

Interventions

3-Iodobenzylguanidine 3 tipifarnib 1 pazopanib 1 lutetium Lu 177 dotatate 1 lenvatinib 1 guadecitabine 1 fostamatinib 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Phenoxybenzamine 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Capecitabine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡